According to reports, the most recent lawsuit was filed on April 10 by Jill Dewey against C.R. Bard, maker of the Avaulta mesh. The mesh was reportedly implanted in August 2005 to treat a pelvic organ prolapse, but according to the lawsuit, the patient began suffering health problems, including physical pain, shortly after the mesh was implanted.
To be fair, the Avaulta mesh is not the only mesh device linked to serious side effects. According to the US Food and Drug Administration (7/13/11), "Based on an updated analysis of adverse events reported to the FDA and complications described in the scientific literature, the FDA identified surgical mesh for transvaginal repair of POP [pelvic organ prolapse] as an area of continuing serious concern." Unlike many reports of side effects that are often referred to as "rare," the FDA took the step of warning patients that serious complications associated with surgical mesh are "not rare," a heightened warning from the FDA's previous stance.
READ MORE BARD AVAULTA TVM LEGAL NEWS
"The FDA's literature review found that erosion of the mesh through the vagina is the most common and consistently reported mesh-related complication from transvaginal POP surgeries using mesh," the FDA wrote (italics in original).
Furthermore, the FDA reported, the use of surgical mesh for pelvic organ prolapse or stress urinary incontinence did not improve results or quality of life compared with patients who received non-mesh repair. In other words, transvaginal mesh (which includes Avaulta) may not be as effective as other treatments and may have more risks.